Fingolimod Hydrochloride
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
C19H33NO2 · HCl 343.93
1,3-Propanediol, 2-amino-2-[2-(4-octylphenyl)ethyl]-, hydrochloride;
2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol hydrochloride CAS RN®: 162359-56-0. Fingolimod (free base)
C19H33NO2 307.48 CAS RN®: 162359-55-9.
1 DEFINITION
Fingolimod Hydrochloride contains NLT 98.0% and NMT 102.0% of fingolimod hydrochloride (C19H33NO2 · HCl), calculated on an anhydrous and solvent-free basis.
2 IDENTIFICATION
Change to read:
A. Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197A or 197M (CN 1-May-2020)
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
C. Identification Tests - General 〈191〉, Chemical Identification Tests, Chloride
3 ASSAY
3.1 Procedure
Solution A: 0.1% phosphoric acid in water
Mobile phase: See Table 1.
Table 1
| Time (min) | Solution A (%) | Acetonitrile (%) |
|---|---|---|
| 0 | 80 | 20 |
| 20 | 5 | 95 |
| 23 | 5 | 95 |
| 23.1 | 80 | 20 |
| 33 | 80 | 20 |
Diluent: Acetonitrile and Solution A (1:1)
Standard solution: 0.6 mg/mL of USP Fingolimod Hydrochloride RS in Diluent
Sample solution: 0.6 mg/mL of Fingolimod Hydrochloride in Diluent
3.2 Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 215 nm
Column: 3-mm × 15-cm; 3-μm packing L1
Column temperature: 40°
Flow rate: 0.8 mL/min
Injection volume: 5 μL
3.3 System suitability
Sample: Standard solution
3.4 Suitability requirements
Relative standard deviation: NMT 0.73%
Tailing factor: NMT 5
3.5 Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of fingolimod hydrochloride (C19H33NO2 · HCl) in the portion of Fingolimod Hydrochloride taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response from the Sample solution
rS = peak response from the Standard solution
CS = concentration of USP Fingolimod Hydrochloride RS in the Standard solution (mg/mL)
CU = concentration of Fingolimod Hydrochloride in the Sample solution (mg/mL)
Acceptance criteria: 98.0%–102.0% on an anhydrous and solvent-free basis
4 IMPURITIES
Residue on Ignition 〈281〉: NMT 0.1%
Organic Impurities
Solution A, Mobile phase, Diluent, Sample solution, and Chromatographic system: Proceed as directed in the Assay.
System suitability solution: 0.6 mg/mL of USP Fingolimod System Suitability Mixture RS in Diluent
Standard stock solution: Use the Standard solution from the Assay.
Standard solution: 0.003 mg/mL of USP Fingolimod Hydrochloride RS from the Standard stock solution in Diluent
Sensitivity solution: 0.3 μg/mL of USP Fingolimod Hydrochloride RS from the Standard solution in Diluent
System suitability
Samples: System suitability solution, Standard solution, and Sensitivity solution
[Note - The relative retention times of fingolimod and O-acetyl fingolimod are about 1.00 and 1.11, respectively.]
Suitability requirements
Resolution: NLT 1.2 between O-acetyl fingolimod and fingolimod nonyl homolog; NLT 0.8 between 2-phenethyl fingolimod analog and 3-phenethyl fingolimod analog, System suitability solution
Relative standard deviation: NMT 10%, Standard solution
Signal-to-noise ratio: NLT 10, Sensitivity solution
Analysis
Samples: Sample solution and Standard solution
Calculate the percentage of each individual impurity in the portion of Fingolimod Hydrochloride taken:
Result = (rU/rS) × (CS/CU) × (1/F) × 100
rU = peak area of each impurity from the Sample solution
rS = peak area of fongolimod hydrochloride from the Standard solution
CS = concentration of USP Fingolimod Hydrochloride RS in the Standard solution (mg/mL)
CU = concentration of Fingolimod Hydrochloride in the Sample solution (mg/mL)
F = relative response factor for each individual impurity (see Table 2)
Acceptance criteria: See Table 2. The reporting threshold is 0.05%.
Table 2
| Name | Relative Retention Time | Relative Response Factor | Acceptance Criteria, NMT (%) |
|---|---|---|---|
| Fingolimod | 1.00 | – | – |
| Fingolimod hexyl homolog | 0.82 | 1.1 | 0.5 |
| Fingolimod heptyl homolog | 0.93 | 1.0 | 0.2 |
| Fingolimod nonyl homolog | 1.13 | 1.0 | 0.2 |
| Fingolimod decyl homolog | 1.23 | 1.0 | 0.5 |
| 3-Phenethyl fingolimod analog | 1.97 | 1.3 | 0.2 |
| 2-Phenethyl fingolimod analog | 2.00 | 1.4 | 0.2 |
| Any individual unspecified impurity | – | 1.0 | 0.10 |
| Total impurities | – | – | 1.0 |
5 SPECIFIC TESTS
Water Determination 〈921〉, Method I: NMT 0.5%
Microbial Enumeration Tests 〈61〉 and Tests for Specified Microorganisms 〈62〉: The total aerobic microbial count is NMT 103 cfu/g. The total combined molds and yeasts count is NMT 102 cfu/g.
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in well-closed containers. Store below 30° in a dry place.
USP Reference Standards 〈11〉
USP Fingolimod Hydrochloride RS
USP Fingolimod System Suitability Mixture RS
It contains Fingolimod Hydrochloride and small amounts of the following impurities:
O-Acetyl fingolimod;
2-Amino-2-(hydroxymethyl)-4-(4-octylphenyl)butyl acetate.
C21H35NO3 349.51
Fingolimod decyl homolog;
2-Amino-2-(4-decylphenethyl)propane-1,3-diol. C21H37NO2 335.53
Fingolimod heptyl homolog;
2-Amino-2-(4-heptylphenethyl)propane-1,3-diol. C18H31NO2 293.45
Fingolimod hexyl homolog;
2-Amino-2-(4-hexylphenethyl)propane-1,3-diol. C17H29NO2 279.42
Fingolimod nonyl homolog;
2-Amino-2-(4-nonylphenethyl)propane-1,3-diol. C20H35NO2 321.51
2-Phenethyl fingolimod analog;
2-Amino-2-[4-octyl-2-(4-octylphenethyl)phenethyl]propane-1,3-diol. C35H57NO2 523.85
3-Phenethyl fingolimod analog;
2-Amino-2-[4-octyl-3-(4-octylphenethyl)phenethyl]propane-1,3-diol. C C35H57NO2 523.85

